Emerging Growth Trends Driving Rapid Expansion in the Needle Market

The needle market is on the verge of significant expansion, driven by evolving healthcare needs and technological advancements. As the demand for safer and more efficient needle solutions continues to rise, the industry is set to experience substantial growth and innovation in the coming years. Here is a detailed overview of the market's expected value, key players, emerging trends, and segment dynamics.

Forecasted Growth and Market Size of the Needle Market by 2030
The needle market is anticipated to grow robustly, reaching a valuation of $12.27 billion by 2030. This expansion is expected at a compound annual growth rate (CAGR) of 6.6%. Several factors contribute to this upward trend, including enhanced attention to healthcare worker safety, increased adoption of home-based care and self-injection methods, the rising global prevalence of diabetes, growth in outpatient and ambulatory care services, and a growing preference for minimally invasive medical procedures. Key market trends include the widespread use of safety needles to reduce needle-stick injury risks, growing demand for disposable and single-use needles, increased utilization of pen needles for diabetes treatment, expanding applications in blood collection and diagnostic testing, and a shift toward sterile, pre-packaged needle products.

Download a free sample of the needle market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15614&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Leading Companies Driving the Needle Market Forward
The needle market features a range of prominent players that dominate the industry landscape. These include Becton dic*kinson, Terumo Corporation, B. Braun AG, NIPRO Corporation, Smiths Medical, Cardinal Health, Hindustan Syringes and Medical Devices, Retractable Technologies, Owen Mumford, Ypsomed, Vygon, ICU Medical, Novo Nordisk, Medtronic, Boston Scientific, Cook Medical, Stryker, Teleflex, Nipro Medical Europe, and Baxter International.
In a notable development in August 2024, Medical Technology and Devices S.p.A. (MTD), an Italian medical device manufacturer, acquired Ypsomed's pen-needle and blood-glucose-monitoring (BGM) business. This acquisition boosted MTD's pen-needle production capacity to over 2.5 billion units annually, strengthening its global leadership position. Ypsomed Holding AG, based in Switzerland, is recognized for its diabetes care technologies, including injection and monitoring solutions.

Innovations and Opportunities Shaping the Needle Industry Landscape
Innovation is at the forefront of the needle market, with companies focusing on developing advanced products that enhance minimally invasive diagnostic and therapeutic procedures. A prime example is the introduction of cutting-edge conventional transbronchial needles designed for bronchoscopy. These devices are used to collect tissue samples from the lungs and surrounding areas with greater precision and less invasiveness. In September 2023, Broncus Medical Inc., a US-based medical technology firm, launched the BIOSTAR needle system-a modern conventional transbronchial needle aspiration (cTBNA) and endobronchial ultrasound-guided TBNA (EBUS-TBNA) solution. These needles offer improved diagnostic accuracy, sample quality, and sensitivity compared to traditional methods, especially useful in lung cancer staging and sarcoidosis diagnosis. The BIOSTAR needles come in various gauges-25G, 22G, 21G, and 19G-which affect the amount and quality of the samples collected, as well as the level of blood aspiration. This innovation marks a significant step forward in enhancing patient outcomes through minimally invasive diagnostics.

View the full needle market report:
https://www.thebusinessresearchcompany.com/report/needle-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Needle Market Segmentation and Dominant Categories
The needle market is categorized into several segments to better understand its structure and key revenue drivers.
1) By Type: Conventional Needles and Safety Needles
2) By Application: Pen Needles for Diabetes, Blood Collection Needles, Needles for Ophthalmic Procedures, and Dentistry Needles
3) By End User: Hospitals, Clinics, Diagnostic Centers, and Home-Based Care Settings
Further subcategories break down the types of needles used:
- Conventional Needles include Hypodermic Needles, Intravenous (IV) Needles, Insulin Needles, and Blood Collection Needles.
- Safety Needles include Safety Hypodermic Needles, Safety Insulin Needles, Safety Blood Collection Needles, and Auto-Disable Safety Needles.
This detailed segmentation highlights the diverse applications and specialized designs that address different medical needs across various healthcare environments.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.